Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

• Autor(es): Nicolau, José Carlos
• Data: 2019
• Origem: Oasisbr
• Assunto(s): ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
• Tipo de Documento: Artigo científico
• Idioma: Inglês